| | 540737-29-9 Basic information More.. |
| Product Name: | Tofacitinib citrate | | Synonyms: | 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1);CP-690550 (Tofacitinib citrate);CP 690500-10;CP 690550-10;1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R,4R)-, citrate;1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE;Tofacitinib citrate, >=98%;1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | | CAS: | 540737-29-9 | | MF: | C16H20N6O.C6H8O7 | | MW: | 504.497 | | EINECS: | 638-826-4 | | Mol File: | 540737-29-9.mol |  |
Use
Tofacitinib citrate has been used as a ligand for human serum albumin in fluorescence quenching, dynamic light scattering (DLS) measurements, differential scanning calorimetry and molecular docking studies, as a medium supplement for full depth articular cartilage (FDC) explants to monitor cytokine-induced proteoglycan loss, and as a Janus kinase inhibitor in MCF7 breast cancer cells
- Tofacitinib Citrate
-
- US $0.00 / g
- 2024-09-25
- CAS:540737-29-9
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Tofacitinib Citrate
-
- US $0.00 / Kg/Bag
- 2024-09-24
- CAS:540737-29-9
- Min. Order: 2Kg/Bag
- Purity: 99% up
- Supply Ability: 20tons
- Tofacitinib Citrate
-
- US $0.00-0.00 / mg
- 2024-09-20
- CAS:540737-29-9
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
|
540737-29-9
Recommend Suppliers |
|